ADVANCE 2024: Updates on Clinical Trials for Sanfilippo Syndrome (Part 2)
ADVANCE 2024: Updates on Clinical Trials for Sanfilippo Syndrome (Part 1)Подробнее
ADVANCE 2024: Impact of Sanfilippo on the RetinaПодробнее
ADVANCE 2024: Deep Dive Gene Therapy ConsiderationsПодробнее
SCF Solving Sanfilippo Symposium 2024 PART 2Подробнее
ADVANCE 2024: Introduction keynoteПодробнее
ADVANCE 2024: Drug Repurposing Studies for Sanfilippo SyndromeПодробнее
ADVANCE 2024: The Advantage of Qualitative Interviews in Clinical TrialsПодробнее
ADVANCE 2024: Advances in Preclinical Research For SanfilippoПодробнее
ADVANCE 2024: Deep Dive: Mitochondria & Metabolism in SanfilippoПодробнее
ADVANCE 22 Sanfilippo conference - Day 2, Part 3Подробнее
ADVANCE 22 Sanfilippo conference - Day 2, Part 1Подробнее
Clinical Trials: A Mom on the Pioneers and Those Who Come After.Подробнее
Clinical Trials: A Mom on Waiting for an Emerging Therapy.Подробнее
SCF Solving Sanfilippo Symposium 2024 PART 1Подробнее
Update on Ultragenyx's Sanfilippo syndrome Type A Gene Therapy program (UX111) - March 26, 2024Подробнее
ADVANCE 22 Sanfilippo conference - Day 2, Part 2Подробнее
Clinical Trials: Two Children Screened; One Qualifies, Antibodies Exclude the OtherПодробнее